Thursday February 21, 2019

High BP Medicine May Help Treat Migraine

Migraines are thought to affect a staggering one billion people worldwide

0
//
High BP Medicine May Help Treat Migraine
High BP Medicine May Help Treat Migraine. Pixabay

A medication originally used to treat high blood pressure may help you from migraine pain attacks.
Candesartan – a drug used to treat high blood pressure – is just as effective as the commonly prescribed propranolol for migraine sufferers, according to a study.

The researchers also found that candesartan may work for patients who get no relief from propranolol.

“This gives doctors more possibilities and we can help more people,” said professor Lars Jacob Stovner, from Norwegian University of Science and Technology (NTNU).

“Candesartan is already in use by several doctors as a migraine preventive medicine but our follow-up study provides the proof that the drug actually works as a treatment,” said the researchers.

Representational image.
Representational image. Pixabay

The NTNU study was a triple blind test, which means that neither patients nor doctors nor those who analysed the results knew whether the patients had been given placebo or real medicine, Stovner said.

Researchers tested both candesartan and propranolol in 72 patients.

These patients were normally affected by migraine attacks at least twice every month.

The patients used each treatment (candesartan, propranolol or placebo) for 12 weeks.

More than 20 percent of migraine patients reported that they feel better even when they are given a placebo.

Also Read: Why migraines are more common among women

But blind tests show that candesartan works preventively for another 20 to 30 percent of patients.

“The hope is now that candesartan will be even more commonly prescribed,” said Stovner.

Migraines are thought to affect a staggering one billion people worldwide. (IANS)

Next Story

Shortage Of Blood Pressure Drugs After Recall: FDA

The agency said that it determined that the impurities "may be generated when specific chemicals and reaction conditions are present in the manufacturing process"

0
Blood Pressure, Drugs
A man has his blood pressure checked at a clinic in Wise, Virginia, July 22, 2017. VOA

Additional shortages of blood pressure drugs in the United States are possible following recent recalls related to traces of a probable carcinogen found in some versions a particular class of hypertension medicines, the U.S. Food and Drug Administration said Friday.

The drugs, including valsartan, belong to a class of widely-used medicines for treating high blood pressure called angiotensin II receptor blockers, or ARBs. Valsartan is the generic of Novartis’ Diovan.

The FDA also said it may have identified the root cause of the potentially cancer-causing impurities but that it is still investigating.

The recalls began last summer after the FDA was informed that ingredients used by Chinese manufacturer Zhejiang Huahai Pharmaceuticals Co (Huahai) to produce valsartan contained the impurities. The FDA later halted all imports from one of Huahai’s factories.

Drugs
Some generic versions of other ARBS, such as losartan and irbesartan, have also been recalled.

Other manufacturers have also had to recall valsartan after the impurities were found in their versions of the drug.

It is currently listed as in shortage by the FDA.

Generic drugs

Some generic versions of other ARBS, such as losartan and irbesartan, have also been recalled. The most recent recall was announced earlier this week.

Also Read: New Wearable Patch That Helps in Monitoring Blood Pressure

The agency said that it determined that the impurities “may be generated when specific chemicals and reaction conditions are present in the manufacturing process” and “may also result from the reuse of materials, such as solvents.”

The reuse of solvents is an accepted practice in the industry, but manufacturers are generally expected to ensure that reused materials meet certain safety standards. (VOA)